News

MEGIN launches side-by-side dual-MEG hyperscanning facility at Tsinghua University in Beijing, giving researchers a real-time window into how two brains interact during natural conversation, cooperation, and play.

MEGIN and BESA GmbH today announced a significantly expanded strategic partnership designed to bring AI-enabled and computationally advanced analytical methods into the clinical and research MEG workflow.

MEGIN installs the first MEG Maps™ enabled TRIUX™ neo system in Japan at the National Institute for Minamata Disease (NIMD) in Minamata.

Research from Boys Town using MEG hopes to understand differences in processing for children who wear hearing aids. They hope this knowledge will help every child get what they need to succeed—academically and in life.

MEG research from Simon Fraser University (SFU) may help patients with Parkinson’s disease (PD) receive more effective, personalized treatment.

MEGIN announces new Distributor partnership with Aerobe and shares new MEG research on best practices, sleep quality, motor imagery, mTBI, and emotional processing.

MEGIN is pleased to announce a new distributor partnership with Aerobe, strengthening MEGIN’s presence and service capabilities across the Indian market.

MYndspan, the first company to offer clinical-grade MEG brain scanning to consumers, today announced findings linking sleep quality to changes in brain function and cognition.

After many successful epilepsy surgeries, University of Florida Health is now using MEG, technology to redefine the treatment and evaluation of brain tumors.